The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1664-5464|1|1|150-162

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.1, Iss.1, 2011-06, pp. : 150-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 110-110

Karger

Access to resources Recommend Favorite

Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 29, Iss. 5, 2010-05 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Reply to the Letter by Deleu: Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 111-111

Karger

Access to resources Recommend Favorite

Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 3-4, 2004-10 ,pp. : 278-298

Karger

Access to resources Recommend Favorite